American Shared Hospital Services — Cyborg Score 3/10

Strategic Profile

The company operates through two segments: Leasing (medical equipment leasing) and Retail (facilities in Peru and Ecuador). In Q1 2025, the company reported 17% year-over-year revenue growth to $6.1 million, with direct patient services seeing 224% growth driven by a Rhode Island acquisition and new Puebla, Mexico facility.

Cyborg Score Rationale

The company has a minimal market cap of $14 million. The company reported a net loss of $625,000 in Q1 2025 compared to net income of $119,000 in Q1 2024. While expansion efforts are underway, profitability challenges and micro-cap valuation present significant headwinds.

Top Insights

• Q1 2025 revenue grew 17% year-over-year to $6.1 million, with direct patient services surging 224% from Rhode Island acquisition and Puebla facility
• Medical equipment leasing revenue declined to $3.0 million from $4.3 million, creating a mixed revenue picture
• The company maintains $11.5 million in cash and plans expansion through new facilities in Guadalajara, Mexico, and Rhode Island
• Stock price stood at $1.49 as of May 28, 2026

Named Competitors

• Concord Medical Services — Diagnostic imaging and radiation oncology services
• The Oncology Institute — Cancer treatment and oncology services
• Assure Holdings — Intraoperative neuromonitoring services

Recent Developments

• (Q1 2025) Reported 17% YoY revenue growth to $6.1 million with direct patient services up 224%
• (2025) Acquired Rhode Island Radiation Therapy Cancer Centers adding $9-10M in annual revenue
• (2025) Opened new Puebla, Mexico radiation therapy center

Open the full interactive American Shared Hospital Services report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.